High frequency of rearrangement of the RET protooncogene (RET/PTC) in Chinese papillary thyroid carcinomas

J Clin Endocrinol Metab. 1998 May;83(5):1629-32. doi: 10.1210/jcem.83.5.4774.

Abstract

The activation of RET protooncogene, through chromosomal translocation, is unique to papillary thyroid carcinomas. Rearrangement of the RET kinase domain to 3 partner genes has been described, of which the RET/PTC1 is the most common. To investigate the frequency of RET rearrangement in Chinese papillary thyroid carcinomas, we have performed RT-PCR to amplify specific RET/PTC transcripts. Among the papillary thyroid carcinomas of 11 patients examined, we have identified 2 containing RET/PTC1, 3 containing RET/PTC2, and 1 containing RET/PTC3 oncogenes. Although the cause of the high frequency of RET/PTC oncogenes in Chinese papillary thyroid carcinomas is unknown, our study suggests that RET rearrangement is an important genetic lesion underlying the development of thyroid papillary carcinoma in Taiwan.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Base Sequence
  • Carcinoma, Papillary / genetics*
  • DNA, Neoplasm / analysis
  • DNA, Neoplasm / chemistry
  • Drosophila Proteins*
  • Gene Rearrangement*
  • Humans
  • Middle Aged
  • Polymerase Chain Reaction
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins c-ret
  • RNA-Directed DNA Polymerase
  • Receptor Protein-Tyrosine Kinases / genetics*
  • Taiwan
  • Thyroid Neoplasms / genetics*

Substances

  • DNA, Neoplasm
  • Drosophila Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-ret
  • Receptor Protein-Tyrosine Kinases
  • Ret protein, Drosophila
  • RNA-Directed DNA Polymerase